DelveInsight’s X-Linked Retinitis Pigmentosa epidemiology forecast report provides a comprehensive understanding of X-Linked Retinitis Pigmentosa, historical and forecasted epidemiology, and X-Linked Retinitis Pigmentosa trends in the 7MM (the United States, EU5 (France, Italy, Spain, the UK, and Germany), and Japan).
Key Takeaways from the X-Linked Retinitis Pigmentosa Epidemiology Forecast Report
As per DelveInsight estimates, the total X-Linked Retinitis Pigmentosa prevalent cases was 250,911 in the 7MM in 2020, and it is expected to rise at a CAGR of 0.52% by 2030.
Among the EU5 countries, Germany has the highest X-Linked Retinitis Pigmentosa diagnosed cases, while Spain had the least in 2020.
Among the numerous XLRP mutations, RPGR is the most frequent in Japan in 2020.
According to DelveInsight XLRP epidemiology analysis, Non-Syndromic Retinitis Pigmentosa is more common than Syndromic and Systemic Retinitis Pigmentosa.
To learn more about the symptoms, diagnosis, and treatment, request for sample @ X-Linked Retinitis Pigmentosa Treatment
X-Linked Retinitis Pigmentosa: Overview
X-Linked Retinitis Pigmentosa (XLRP) is severe genetic photoreceptor dystrophy that causes blindness at a median age of 45 years. Hence it mainly affects men. XLRP is linked to X chromosome gene mutations. The mutant gene is carried by mothers on one of their X chromosomes and passed on to their sons in this kind of inheritance.
X-Linked Retinitis Pigmentosa Epidemiology Segmentation
The X-Linked Retinitis Pigmentosa report proffers epidemiological analysis for the study period 2018-30 in the 7MM segmented into:
Retinitis Pigmentosa Total Prevalence
Retinitis Pigmentosa Diagnosed Prevalence
Retinitis Pigmentosa Type-Specific Diagnosed Prevalence
X-Linked Retinitis Pigmentosa Gene Mutation Specific Cases
Get a detailed analysis of epidemiology segmentation @ X-Linked Retinitis Pigmentosa Epidemiology
Table of Contents
1.
Key Insights
2.
Report Introduction
3.
X-Linked Retinitis Pigmentosa (XLRP) Epidemiology Overview at a Glance
4.
Executive Summary of X-linked Retinitis Pigmentosa (XLRP)
5.
X-Linked Retinitis Pigmentosa: Disease Background and Overview
6.
X-Linked Retinitis Pigmentosa Epidemiology and Patient Population
7.
Patient Journey
8.
KOL Views
9.
Appendix
10.
DelveInsight Capabilities
11.
Disclaimer
12.
About DelveInsight
For rich insights into Healthcare and Pharmaceutical News, visit Pharma, Healthcare, and Biotech Blog Posts
Related Reports
Retinitis Pigmentosa Epidemiology Forecast
DelveInsight’s ‘Retinitis Pigmentosa (RP) – Epidemiology Forecast to 2030’ report explains the disease’s historical and forecasted Retinitis Pigmentosa (RP) epidemiology in the 7MM.
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
Media ContactCompany Name: DelveInsight Business Research LLPContact Person: Sandeep JoshiEmail: Send EmailPhone: 9193216187Address:304 S. Jones Blvd #2432 City: Las VegasState: NVCountry: United StatesWebsite: www.delveinsight.com/